Stonehage Fleming Financial Services Holdings Ltd Acquires 394 Shares of Elevance Health, Inc. (NYSE:ELV)

Stonehage Fleming Financial Services Holdings Ltd grew its holdings in Elevance Health, Inc. (NYSE:ELV) by 20.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,300 shares of the company’s stock after purchasing an additional 394 shares during the quarter. Stonehage Fleming Financial Services Holdings Ltd’s holdings in Elevance Health were worth $848,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in ELV. Regatta Capital Group LLC boosted its holdings in shares of Elevance Health by 19.5% during the 4th quarter. Regatta Capital Group LLC now owns 888 shares of the company’s stock worth $328,000 after buying an additional 145 shares in the last quarter. Asio Capital LLC lifted its position in shares of Elevance Health by 12.6% during the 4th quarter. Asio Capital LLC now owns 10,910 shares of the company’s stock valued at $4,025,000 after acquiring an additional 1,221 shares during the period. Archford Capital Strategies LLC boosted its stake in Elevance Health by 14.0% during the fourth quarter. Archford Capital Strategies LLC now owns 3,959 shares of the company’s stock worth $1,460,000 after acquiring an additional 487 shares in the last quarter. Flagship Harbor Advisors LLC grew its holdings in Elevance Health by 29.3% in the fourth quarter. Flagship Harbor Advisors LLC now owns 794 shares of the company’s stock worth $293,000 after purchasing an additional 180 shares during the period. Finally, B.O.S.S. Retirement Advisors LLC bought a new stake in Elevance Health in the fourth quarter valued at $280,000. Institutional investors own 89.24% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ELV. Truist Financial cut their price objective on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Barclays raised their price objective on Elevance Health from $501.00 to $512.00 and gave the company an “overweight” rating in a research note on Friday. Stephens lowered Elevance Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $520.00 to $440.00 in a research report on Wednesday, January 22nd. Wells Fargo & Company reduced their price target on shares of Elevance Health from $593.00 to $495.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Finally, Mizuho lowered their price objective on shares of Elevance Health from $585.00 to $505.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $525.60.

Elevance Health Trading Up 0.0 %

NYSE ELV opened at $401.43 on Monday. The stock has a market capitalization of $93.10 billion, a price-to-earnings ratio of 14.63, a PEG ratio of 1.11 and a beta of 0.84. The business’s fifty day moving average is $386.21 and its 200-day moving average is $461.87. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.50 and a quick ratio of 1.50. Elevance Health, Inc. has a one year low of $362.21 and a one year high of $567.26.

Elevance Health (NYSE:ELV) last released its earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. Equities research analysts predict that Elevance Health, Inc. will post 32.95 EPS for the current year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be paid a dividend of $1.71 per share. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date is Monday, March 10th. This represents a $6.84 annualized dividend and a dividend yield of 1.70%. Elevance Health’s dividend payout ratio is presently 23.77%.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.